论文部分内容阅读
目的探讨依达拉奉治疗脑出血的疗效。方法将120例脑出血患者随机分为治疗组和对照组,治疗组在常规治疗的基础上给予依达拉奉治疗,14d为1个疗程。分别比较两组治疗前及治疗后7d和14d神经功能缺损程度(national institute of health stroke scale,NIHSS)评分,Glassgow评分,治疗前、后查血、尿常规、出凝血时间,肝、肾功能,心电图。结果与对照组比较,治疗组治疗后7d和14d的NIHSS评分均明显低于对照组(P<0.05);Glassgow评分有统计学意义(P<0.05);临床疗效有统计学意义(P<0.05)。结论依达拉奉治疗脑出血能显著提高基本治疗率。
Objective To investigate the therapeutic effect of edaravone on cerebral hemorrhage. Methods 120 patients with cerebral hemorrhage were randomly divided into treatment group and control group. The treatment group was treated with edaravone on the basis of conventional treatment, and the treatment group was treated with 14 courses of treatment. The levels of National Institute of Health Stroke (NIHSS), Glassgow score, blood and urine before and after treatment, clotting time, hepatic and renal function, Electrocardiogram. Results Compared with the control group, the NIHSS scores of the treatment group at 7d and 14d after treatment were significantly lower than those of the control group (P <0.05); the Glassgow score was statistically significant (P <0.05); the clinical effect was statistically significant (P <0.05 ). Conclusion Edaravone treatment of cerebral hemorrhage can significantly improve the basic treatment rate.